Skip to main content

Singular Genomics Systems, Inc.

OMICDelisted Feb 21, 2025
Industry
Laboratory Analytical Instruments
SEC CIK
0001850906

Singular Genomics Systems, Inc. was delisted on Feb 21, 2025; its insiders filed their last Form 4 on Feb 27, 2025; 20 institutions reported holding it in 13F filings for Q4 2024, worth $21.5M in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Singular Genomics Systems, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of OMIC: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders4742−5
Shares26.2M25.4M−817.2K (−3.1%)
Value$12.1M$13.1M+$967.8K (+8.0%)

New holders (2)

Institutions that held Singular Genomics Systems, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to OMIC in Q1 2024
InstitutionSharesValue% of portfolio
Susquehanna International Group, LLP51,125$26.3K0.00%
Palumbo Wealth Management LLC12,549$6.45K0.00%

Sold out (7)

Institutions that held Singular Genomics Systems, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of OMIC in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Bank of Montreal982,499$481.4K
Cambridge Investment Research Advisors, Inc.26,350$12.0K
Bank of New York Mellon Corp25,543$11.8K
Bay Rivers Group14,000$6.44K
Two Sigma Securities, LLC12,558$5.78K
DAGCO, Inc.1,700$782
Simplex Trading, LLC522$0